Ukurasa 1 kutoka 17248 matokeo
BACKGROUND
Early glottic cancer (stage T1, T2) is connected with very good prognosis as well as organ and function preservation. The aim of the study was the assessment of early glottic treatment results.
METHODS
Between 1999-2005 1007 patients with larynx cancer were treated in Dept. of
Of 1053 patients with primary cancer of the lung, 549 (52%) underwent thoracotomy and 40% a presumably radical resection. Lobectomies were performed in 227 patients (41% of those operated), pneumonectomy in 160 (29%). Early mortality (death within 30 days) was 5.5% with the highest figure (11%)
BACKGROUND
Treatment of early stage rectal cancer has excellent oncological results. To reduce treatment-related mortality and morbidity and improve functional results, a focus on local resections is increasingly important.
OBJECTIVE
The purpose of this study was to compare outcomes after transanal
Methodology to conduct phase I trials in the Early Clinical Trial Group (ECTG) in Europe was reviewed and compared with current status of the trials in Japan. Single dose acute toxicity studies and repeated dose toxicity studies were required in order to enter phase I trials in Europe, while in
OBJECTIVE
The treatment of oral cancer requires an effective rehabilitation strategy such as an early intensive rehabilitation (EIR) program.
METHODS
The medical records and data of 41 patients who participated in an EIR program and 20 control group patients were analyzed. These patients all
Patients with early-stage glottic cancer are primarily treated with one of three options: endoscopic laser excision, external-beam radiation, or open conservation surgery. We sought to determine patient preferences for treatment when presented with a choice between CO2 laser resection and radiation
A recent National Institutes of Health consensus guideline recommends the general use of adjuvant hormonal therapy for the treatment of early breast cancer in postmenopausal women with estrogen receptor-positive tumors. Standard therapy has been 5 years of tamoxifen, but about 30% of those patients
Skeletal finds have shown that tumorous diseases are as old as mankind itself. However, the appearance of such diseases have been rather differently understood, explained and treated throughout the history of medicine. This paper gives a brief survey of the development of cancer treatment and